NCT06571500招募中不适用
Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Beta-cell function
研究概览
简要总结
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a family history of type 2 diabetes at the University of Missouri. Our aim is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 to 59 years old
- •body mass index ≥30.0 kg/m2 and <45.0 kg/m2
- •Additional, group-specific inclusion criteria:
- •Family history of type 2 diabetes: first degree relative with type 2 diabetes
- •Control group: no family history of type 2 diabetes
排除标准
- •Pregnant, planning to become pregnant during the study, or breastfeeding
- •Current diagnosis or history of type 1 or type 2 diabetes
- •Use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
- •History of bariatric surgery
- •Known, uncontrolled hypothyroidism
- •History of intracranial hypertension, including papilledema, or a condition that increases the risk of developing intracranial hypertension, such as Turner Syndrome, Prader-Willi Syndrome, or renal impairment
- •Current cancer or cancer that has been in remission less than 5 years
- •First degree relative with type 1 diabetes diagnosis
- •Evidence of significant anemia or significant end organ dysfunction (e.g., liver, kidney, heart disease)
- •Alcohol use disorder, use of controlled substances, or smoking >2 cigarettes per day
- •Greater than 3% weight loss within three months of screening or engaged in regular (≥3 days per week), continuous moderate- or high-intensity exercise of ≥30 min duration
- •Mentally disabled persons, prisoners, and persons with inability to grant voluntary informed consent
结局指标
主要结局
Beta-cell function
时间窗: 15, 30, 60, 120, 240, and 360 min and 7 days after rhGH administration
Insulin secretion rate in relationship to plasma glucose
次要结局
未报告次要终点
研究者
Bettina Mittendorfer
Senior Associate Dean for Research; Professor, Medicine & Nutrition; NextGen Director of Clinical and Translational Sciences Unit
University of Missouri-Columbia
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Growth Hormone Resistance of Beta-cells AGestational DiabetesHealthyObesityNCT06571487University of Missouri-Columbia30
已完成
2 期
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2NCT00321321University Hospital, Gentofte, Copenhagen12
已完成
不适用
Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113)Type 2 DiabetesNCT01472341Merck Sharp & Dohme LLC507
Unknown
不适用
Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy SubjectsPregnancyGestational Diabetes Mellitus (GDM)Type 2 DiabetesNCT02025673Qingdao University200
已完成
不适用
Study to Investigate the Pathophysiology of Type 2 Diabetes in YouthImpaired Glucose TolerancePre-diabetesMetabolic SyndromeInsulin ResistanceChildhood ObesityNCT00536250Yale University255